Pharmacogenomics spotlight commentary: From the United Kingdom to global populations
Br J Clin Pharmacol
.
2021 Dec;87(12):4546-4548.
doi: 10.1111/bcp.14917.
Epub 2021 May 25.
Authors
Emma F Magavern
1
2
,
Ann K Daly
3
,
Annette Gilchrist
4
,
Dyfrig A Hughes
5
6
Affiliations
1
William Harvey Research Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK.
2
Department of Clinical Pharmacology, Cardiovascular Medicine, Barts Health NHS Trust, London, UK.
3
Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, UK.
4
Department of Pharmaceutical Sciences, Chicago College of Pharmacy - Downers Grove, Midwestern University, Downers Grove, Illinois, USA.
5
Centre for Health Economics and Medicines Evaluation, Bangor University, Bangor, UK.
6
Department of Molecular and Clinical Pharmacology, University of Liverpool, Liverpool, UK.
PMID:
34036624
DOI:
10.1111/bcp.14917
No abstract available
MeSH terms
Humans
Pharmacogenetics*
United Kingdom